Celularity Inc (CELU)
3.04
-0.01
(-0.33%)
USD |
NASDAQ |
May 17, 16:00
3.04
0.00 (0.00%)
After-Hours: 20:00
Celularity Profit Margin (Quarterly): -2.48K% for Sept. 30, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -2.48K% |
| June 30, 2023 | -1.63K% |
| March 31, 2023 | -1.63K% |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | -1.06K% |
| Date | Value |
|---|---|
| December 31, 2021 | -83.20% |
| September 30, 2021 | |
| June 30, 2021 | -2.02K% |
| March 31, 2021 | -3.07K% |
| December 31, 2020 | |
| September 30, 2020 | -1.38K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-3.07K%
Minimum
Mar 2021
-83.20%
Maximum
Dec 2021
-1.67K%
Average
-1.63K%
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -122.2% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -135.9% |
| Return on Assets | -56.54% |
| Return on Invested Capital | -106.8% |
| Gross Profit Margin (Quarterly) | 4.86% |
| Operating Margin (Quarterly) | -436.9% |
| Return on Net Operating Assets | -68.27% |